Fujian Cancer Hospital: Uterine Cervical Neoplasms trials

The registry lists 10 Uterine Cervical Neoplasms studies with Fujian Cancer Hospital as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SKB264 Plus QL1706 in Recurrent or Metastatic Cervical CancerRecruitingNCT07256236Phase 2
• Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)RecruitingNCT07055399Phase 2
• Nituzumab Plus Serplulimab Combined With SBRT in Cervical CancerRecruitingNCT06455072Phase 2
• Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical CancerRecruitingNCT06455046Phase 2
• MRI-based Signatures for Survival Prediction in Cervical Cancer With RadiotherapyNot yet recruitingNCT06197126
• Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical CancerNot yet recruitingNCT06149767Phase 2
• Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical CancerRecruitingNCT06140589
• A Predictive Model for Early Metastasis in Cervical Cancer Patients After RadiotherapyNot yet recruitingNCT06101966
• A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical CancerNot yet recruitingNCT06039982
• Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative PeriodCompletedNCT03872635Not applicable